Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Hemorrhage | 47 | 2024 | 1126 | 10.630 |
Why?
|
Endoscopy, Gastrointestinal | 43 | 2024 | 888 | 5.280 |
Why?
|
Hemostasis, Endoscopic | 13 | 2022 | 42 | 4.440 |
Why?
|
Colonoscopy | 20 | 2021 | 1409 | 2.890 |
Why?
|
Endoscopy, Digestive System | 12 | 2019 | 358 | 2.110 |
Why?
|
Stomach Diseases | 5 | 2018 | 134 | 2.020 |
Why?
|
Esophageal Diseases | 3 | 2018 | 167 | 1.570 |
Why?
|
Hospital Mortality | 11 | 2019 | 5349 | 1.510 |
Why?
|
Blood Transfusion | 8 | 2019 | 1309 | 1.460 |
Why?
|
Colonic Polyps | 7 | 2024 | 557 | 1.260 |
Why?
|
Peptic Ulcer Hemorrhage | 4 | 2021 | 47 | 1.200 |
Why?
|
Gastroesophageal Reflux | 11 | 2015 | 836 | 1.190 |
Why?
|
Esophagogastric Junction | 5 | 2007 | 351 | 1.070 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 11 | 2024 | 520 | 0.960 |
Why?
|
Hemostatic Techniques | 3 | 2019 | 116 | 0.920 |
Why?
|
Capsule Endoscopy | 3 | 2023 | 106 | 0.920 |
Why?
|
Endosonography | 15 | 2016 | 626 | 0.900 |
Why?
|
Proton Pump Inhibitors | 7 | 2021 | 552 | 0.880 |
Why?
|
After-Hours Care | 2 | 2015 | 102 | 0.880 |
Why?
|
Gastroenterology | 5 | 2019 | 593 | 0.850 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2541 | 0.810 |
Why?
|
Resuscitation | 3 | 2016 | 679 | 0.810 |
Why?
|
Conscious Sedation | 4 | 2018 | 534 | 0.800 |
Why?
|
Adenoma | 8 | 2021 | 2159 | 0.780 |
Why?
|
Fundoplication | 4 | 2007 | 145 | 0.780 |
Why?
|
Length of Stay | 8 | 2019 | 6498 | 0.770 |
Why?
|
Hospitalization | 7 | 2021 | 10840 | 0.760 |
Why?
|
Duodenal Diseases | 4 | 2017 | 101 | 0.710 |
Why?
|
Adenomatous Polyps | 3 | 2021 | 109 | 0.700 |
Why?
|
Laxatives | 3 | 2019 | 95 | 0.690 |
Why?
|
Pancreatitis | 6 | 2024 | 1087 | 0.650 |
Why?
|
Deep Sedation | 3 | 2018 | 119 | 0.640 |
Why?
|
Disease Management | 4 | 2018 | 2536 | 0.620 |
Why?
|
Electrocoagulation | 3 | 2021 | 156 | 0.620 |
Why?
|
Esophagoscopy | 7 | 2016 | 398 | 0.600 |
Why?
|
Platelet Aggregation Inhibitors | 5 | 2020 | 2763 | 0.600 |
Why?
|
Digestive System Diseases | 3 | 2015 | 152 | 0.580 |
Why?
|
Suture Techniques | 4 | 2007 | 775 | 0.570 |
Why?
|
Endoscopy | 6 | 2017 | 1854 | 0.560 |
Why?
|
Blood Urea Nitrogen | 1 | 2017 | 189 | 0.560 |
Why?
|
Shock, Hemorrhagic | 1 | 2018 | 224 | 0.520 |
Why?
|
Risk Assessment | 11 | 2019 | 24315 | 0.490 |
Why?
|
Rhabdomyosarcoma | 1 | 2018 | 358 | 0.480 |
Why?
|
Omeprazole | 5 | 1999 | 106 | 0.460 |
Why?
|
Pancreatic Neoplasms | 11 | 2019 | 5446 | 0.460 |
Why?
|
Intestinal Polyps | 3 | 2013 | 105 | 0.450 |
Why?
|
Platelet Transfusion | 1 | 2016 | 301 | 0.430 |
Why?
|
Quality Indicators, Health Care | 3 | 2018 | 1805 | 0.420 |
Why?
|
Humans | 154 | 2024 | 768166 | 0.420 |
Why?
|
Decision Support Techniques | 4 | 2016 | 2008 | 0.400 |
Why?
|
Gastric Lavage | 1 | 2011 | 17 | 0.400 |
Why?
|
Early Detection of Cancer | 6 | 2019 | 3239 | 0.390 |
Why?
|
Monitoring, Intraoperative | 3 | 2018 | 948 | 0.380 |
Why?
|
Intestinal Mucosa | 7 | 2013 | 3044 | 0.370 |
Why?
|
Endoscopes, Gastrointestinal | 2 | 2015 | 45 | 0.370 |
Why?
|
Triage | 1 | 2018 | 997 | 0.360 |
Why?
|
Hemostasis, Surgical | 2 | 2021 | 128 | 0.360 |
Why?
|
Duodenal Ulcer | 1 | 2010 | 117 | 0.350 |
Why?
|
Foreign-Body Migration | 1 | 2012 | 220 | 0.350 |
Why?
|
Stomach Ulcer | 1 | 2010 | 118 | 0.350 |
Why?
|
Adenocarcinoma | 6 | 2018 | 6395 | 0.350 |
Why?
|
Colorectal Neoplasms | 9 | 2021 | 6974 | 0.340 |
Why?
|
Respiration, Artificial | 2 | 2019 | 2726 | 0.340 |
Why?
|
Hospital Charges | 3 | 2019 | 347 | 0.340 |
Why?
|
Esophageal Sphincter, Lower | 1 | 2009 | 26 | 0.340 |
Why?
|
Pancreatic Diseases | 2 | 2015 | 354 | 0.340 |
Why?
|
Diagnostic Errors | 1 | 2017 | 1281 | 0.330 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2009 | 45 | 0.330 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2665 | 0.330 |
Why?
|
Patient Compliance | 1 | 2019 | 2697 | 0.320 |
Why?
|
Vena Cava Filters | 1 | 2012 | 270 | 0.320 |
Why?
|
Esophageal Fistula | 1 | 2009 | 60 | 0.320 |
Why?
|
Precancerous Conditions | 4 | 2021 | 985 | 0.320 |
Why?
|
Lactose Intolerance | 2 | 1999 | 28 | 0.320 |
Why?
|
Natural Language Processing | 1 | 2018 | 1203 | 0.320 |
Why?
|
Recurrence | 8 | 2017 | 8509 | 0.310 |
Why?
|
Acute Disease | 9 | 2021 | 7243 | 0.300 |
Why?
|
Gastroscopy | 3 | 2012 | 213 | 0.300 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1135 | 0.300 |
Why?
|
Fistula | 1 | 2009 | 213 | 0.290 |
Why?
|
Clinical Competence | 5 | 2019 | 4858 | 0.290 |
Why?
|
Barrett Esophagus | 4 | 2016 | 495 | 0.290 |
Why?
|
Esophageal and Gastric Varices | 3 | 2014 | 215 | 0.280 |
Why?
|
Acute Coronary Syndrome | 1 | 2020 | 2194 | 0.280 |
Why?
|
Male | 76 | 2019 | 364719 | 0.280 |
Why?
|
Female | 73 | 2019 | 397192 | 0.280 |
Why?
|
Insurance Coverage | 1 | 2019 | 1946 | 0.280 |
Why?
|
Internal Medicine | 1 | 2014 | 1064 | 0.280 |
Why?
|
ROC Curve | 6 | 2017 | 3628 | 0.280 |
Why?
|
Aged | 54 | 2019 | 171504 | 0.280 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2006 | 44 | 0.270 |
Why?
|
Achlorhydria | 3 | 1995 | 8 | 0.270 |
Why?
|
Middle Aged | 59 | 2019 | 223492 | 0.270 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2176 | 0.260 |
Why?
|
Esophageal Neoplasms | 5 | 2016 | 1668 | 0.260 |
Why?
|
Hoarseness | 1 | 2006 | 63 | 0.260 |
Why?
|
Muscle, Smooth | 2 | 2007 | 931 | 0.250 |
Why?
|
Emergency Service, Hospital | 2 | 2016 | 7951 | 0.250 |
Why?
|
Predictive Value of Tests | 12 | 2018 | 15454 | 0.250 |
Why?
|
Internet | 1 | 2017 | 3110 | 0.240 |
Why?
|
Blood Vessels | 1 | 2010 | 1110 | 0.230 |
Why?
|
Stents | 9 | 2024 | 3195 | 0.230 |
Why?
|
Intestinal Absorption | 5 | 1998 | 400 | 0.220 |
Why?
|
Nutritional Status | 3 | 1998 | 1628 | 0.220 |
Why?
|
Patient Readmission | 1 | 2018 | 3288 | 0.220 |
Why?
|
Retrospective Studies | 21 | 2019 | 81762 | 0.220 |
Why?
|
Time Factors | 11 | 2018 | 40218 | 0.220 |
Why?
|
Cathartics | 2 | 2015 | 129 | 0.220 |
Why?
|
Blood Coagulation Disorders | 1 | 2006 | 350 | 0.210 |
Why?
|
Indomethacin | 1 | 2024 | 323 | 0.210 |
Why?
|
Needles | 1 | 2006 | 461 | 0.210 |
Why?
|
Pancreaticoduodenectomy | 1 | 2006 | 515 | 0.210 |
Why?
|
Quality Improvement | 2 | 2015 | 3857 | 0.210 |
Why?
|
Medically Uninsured | 2 | 2019 | 840 | 0.210 |
Why?
|
Lipoma | 1 | 2005 | 296 | 0.200 |
Why?
|
Surgical Instruments | 1 | 2005 | 381 | 0.200 |
Why?
|
Anticoagulants | 4 | 2016 | 4852 | 0.200 |
Why?
|
Severity of Illness Index | 9 | 2019 | 15948 | 0.200 |
Why?
|
Cohort Studies | 15 | 2019 | 41754 | 0.200 |
Why?
|
Pancreatic Cyst | 3 | 2013 | 372 | 0.200 |
Why?
|
Ultrasonography, Interventional | 2 | 2007 | 1523 | 0.200 |
Why?
|
Angiography | 1 | 2007 | 1597 | 0.200 |
Why?
|
Cough | 1 | 2006 | 598 | 0.190 |
Why?
|
Video Recording | 2 | 2019 | 976 | 0.190 |
Why?
|
Epinephrine | 1 | 2005 | 794 | 0.190 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2019 | 1757 | 0.190 |
Why?
|
Myocardial Infarction | 2 | 2020 | 11519 | 0.190 |
Why?
|
Cost of Illness | 1 | 2011 | 1951 | 0.190 |
Why?
|
Vasoconstrictor Agents | 1 | 2005 | 656 | 0.190 |
Why?
|
United States | 15 | 2024 | 73039 | 0.190 |
Why?
|
Guideline Adherence | 3 | 2016 | 2235 | 0.190 |
Why?
|
Pyridines | 1 | 2013 | 2894 | 0.190 |
Why?
|
Contrast Media | 2 | 2012 | 5330 | 0.180 |
Why?
|
Prospective Studies | 17 | 2021 | 54926 | 0.180 |
Why?
|
Neoplasm Staging | 5 | 2019 | 11244 | 0.180 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2021 | 46 | 0.180 |
Why?
|
Pancreas | 2 | 2015 | 1700 | 0.180 |
Why?
|
Gastritis, Atrophic | 3 | 2013 | 31 | 0.180 |
Why?
|
Electronic Health Records | 1 | 2018 | 4887 | 0.180 |
Why?
|
False Negative Reactions | 2 | 2012 | 574 | 0.180 |
Why?
|
Multivariate Analysis | 4 | 2018 | 12077 | 0.170 |
Why?
|
Liver Cirrhosis | 4 | 2015 | 1960 | 0.170 |
Why?
|
Esophagus | 4 | 2015 | 1042 | 0.170 |
Why?
|
Registries | 1 | 2016 | 8375 | 0.170 |
Why?
|
Reminder Systems | 2 | 2021 | 388 | 0.170 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3436 | 0.170 |
Why?
|
Image Enhancement | 1 | 2010 | 2880 | 0.170 |
Why?
|
Prognosis | 8 | 2019 | 30010 | 0.170 |
Why?
|
Practice Guidelines as Topic | 7 | 2016 | 7454 | 0.160 |
Why?
|
Anti-Ulcer Agents | 2 | 1997 | 112 | 0.160 |
Why?
|
Lactobacillus acidophilus | 1 | 1999 | 21 | 0.160 |
Why?
|
Obesity | 2 | 2019 | 13090 | 0.160 |
Why?
|
Colonic Diseases, Functional | 1 | 1998 | 39 | 0.160 |
Why?
|
Intestine, Small | 2 | 2015 | 1217 | 0.160 |
Why?
|
Chest Pain | 1 | 2006 | 1101 | 0.160 |
Why?
|
Treatment Outcome | 18 | 2022 | 65371 | 0.160 |
Why?
|
Digestive System Physiological Phenomena | 1 | 1998 | 15 | 0.160 |
Why?
|
Gastrointestinal Diseases | 4 | 2015 | 1206 | 0.150 |
Why?
|
Antibiotic Prophylaxis | 2 | 2014 | 640 | 0.150 |
Why?
|
Adult | 42 | 2024 | 223646 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 10 | 2016 | 20760 | 0.150 |
Why?
|
Odds Ratio | 3 | 2018 | 9669 | 0.150 |
Why?
|
Colon | 3 | 2017 | 1801 | 0.150 |
Why?
|
Diagnosis, Differential | 7 | 2018 | 13014 | 0.150 |
Why?
|
Gastrointestinal Agents | 2 | 2014 | 511 | 0.140 |
Why?
|
Swine | 4 | 2010 | 5995 | 0.140 |
Why?
|
Catheter Ablation | 2 | 2016 | 2780 | 0.140 |
Why?
|
Risk Factors | 15 | 2024 | 74944 | 0.140 |
Why?
|
Publishing | 1 | 2024 | 837 | 0.140 |
Why?
|
Bile Ducts | 2 | 2015 | 288 | 0.130 |
Why?
|
Societies, Medical | 4 | 2024 | 3968 | 0.130 |
Why?
|
Peptic Ulcer | 3 | 2019 | 214 | 0.130 |
Why?
|
Heart Diseases | 1 | 2009 | 2819 | 0.130 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2009 | 319 | 0.130 |
Why?
|
Pancreatic Pseudocyst | 1 | 2016 | 112 | 0.130 |
Why?
|
Appointments and Schedules | 1 | 2019 | 443 | 0.130 |
Why?
|
Ligation | 2 | 2014 | 446 | 0.130 |
Why?
|
Aged, 80 and over | 19 | 2018 | 59629 | 0.130 |
Why?
|
Automation | 1 | 2018 | 589 | 0.130 |
Why?
|
Esophageal pH Monitoring | 2 | 2007 | 203 | 0.120 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.120 |
Why?
|
Ornithine | 1 | 1995 | 79 | 0.120 |
Why?
|
Antidotes | 1 | 2016 | 138 | 0.120 |
Why?
|
Bariatric Surgery | 2 | 2015 | 1001 | 0.120 |
Why?
|
Vitamin B 12 | 2 | 1994 | 529 | 0.120 |
Why?
|
Postoperative Hemorrhage | 2 | 2015 | 419 | 0.120 |
Why?
|
Gliadin | 1 | 1994 | 80 | 0.120 |
Why?
|
Biopsy, Fine-Needle | 3 | 2013 | 1135 | 0.120 |
Why?
|
Helicobacter Infections | 2 | 2015 | 390 | 0.120 |
Why?
|
Patient Satisfaction | 2 | 2017 | 3488 | 0.120 |
Why?
|
Stomach Neoplasms | 1 | 2005 | 1481 | 0.120 |
Why?
|
Reproducibility of Results | 7 | 2018 | 20227 | 0.110 |
Why?
|
Dyspepsia | 1 | 2015 | 116 | 0.110 |
Why?
|
Biliary Tract Diseases | 1 | 2015 | 159 | 0.110 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2016 | 174 | 0.110 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4860 | 0.110 |
Why?
|
Irritable Bowel Syndrome | 2 | 2013 | 454 | 0.110 |
Why?
|
Sulfonamides | 3 | 2009 | 1982 | 0.110 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 195 | 0.110 |
Why?
|
Follow-Up Studies | 10 | 2016 | 39348 | 0.110 |
Why?
|
Intestinal Perforation | 2 | 2013 | 254 | 0.110 |
Why?
|
Mucous Membrane | 2 | 2016 | 659 | 0.110 |
Why?
|
Octreotide | 1 | 2014 | 156 | 0.110 |
Why?
|
Postoperative Complications | 3 | 2013 | 15832 | 0.110 |
Why?
|
Educational Measurement | 2 | 2019 | 1260 | 0.110 |
Why?
|
Blood Coagulation Factors | 1 | 2016 | 371 | 0.110 |
Why?
|
Hydrogen-Ion Concentration | 5 | 2005 | 2486 | 0.110 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 659 | 0.110 |
Why?
|
Pyrazoles | 3 | 2009 | 2028 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1465 | 0.100 |
Why?
|
Area Under Curve | 1 | 2017 | 1643 | 0.100 |
Why?
|
Vascular Fistula | 1 | 2013 | 50 | 0.100 |
Why?
|
Radiology, Interventional | 1 | 2017 | 483 | 0.100 |
Why?
|
Informed Consent | 2 | 2016 | 1010 | 0.100 |
Why?
|
Hospital Costs | 1 | 2019 | 957 | 0.100 |
Why?
|
Medical History Taking | 1 | 2016 | 779 | 0.100 |
Why?
|
Databases, Factual | 3 | 2018 | 8080 | 0.100 |
Why?
|
Models, Biological | 1 | 2008 | 9495 | 0.100 |
Why?
|
Sensitivity and Specificity | 9 | 2021 | 14729 | 0.100 |
Why?
|
Intestinal Fistula | 1 | 2013 | 146 | 0.100 |
Why?
|
Helicobacter pylori | 1 | 2015 | 380 | 0.100 |
Why?
|
Health Resources | 1 | 2018 | 950 | 0.100 |
Why?
|
Hemoglobins | 2 | 2014 | 1531 | 0.100 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 642 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1157 | 0.090 |
Why?
|
Cholestasis | 2 | 2010 | 385 | 0.090 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1104 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 1997 | 802 | 0.090 |
Why?
|
Balloon Occlusion | 2 | 2014 | 129 | 0.090 |
Why?
|
Liver Failure, Acute | 1 | 1992 | 182 | 0.090 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2013 | 957 | 0.090 |
Why?
|
Intestinal Diseases | 1 | 2015 | 505 | 0.090 |
Why?
|
Colonography, Computed Tomographic | 1 | 2012 | 170 | 0.090 |
Why?
|
Atrial Fibrillation | 1 | 2009 | 5176 | 0.090 |
Why?
|
Age Factors | 3 | 2018 | 18412 | 0.090 |
Why?
|
Physical Examination | 1 | 2016 | 1263 | 0.090 |
Why?
|
Pancreatitis, Chronic | 1 | 2013 | 282 | 0.090 |
Why?
|
Drainage | 1 | 2016 | 1183 | 0.090 |
Why?
|
Urban Population | 1 | 2018 | 2046 | 0.080 |
Why?
|
Logistic Models | 3 | 2016 | 13290 | 0.080 |
Why?
|
Biopsy, Needle | 2 | 2006 | 1622 | 0.080 |
Why?
|
Incidence | 3 | 2015 | 21538 | 0.080 |
Why?
|
Gastric Acid | 3 | 2005 | 98 | 0.080 |
Why?
|
Specialization | 1 | 2014 | 779 | 0.080 |
Why?
|
Biliary Tract Neoplasms | 2 | 2010 | 187 | 0.080 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 1972 | 0.080 |
Why?
|
Constipation | 1 | 2014 | 570 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2012 | 963 | 0.080 |
Why?
|
Income | 1 | 2018 | 1878 | 0.080 |
Why?
|
Fibrinolytic Agents | 2 | 2015 | 2080 | 0.080 |
Why?
|
Extracellular Space | 1 | 2011 | 563 | 0.080 |
Why?
|
Aging | 3 | 1998 | 8744 | 0.080 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2337 | 0.080 |
Why?
|
Cooperative Behavior | 1 | 2016 | 1514 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 2014 | 747 | 0.080 |
Why?
|
Deglutition Disorders | 2 | 2013 | 640 | 0.080 |
Why?
|
Specimen Handling | 1 | 2013 | 708 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1226 | 0.080 |
Why?
|
Ileum | 1 | 2011 | 558 | 0.080 |
Why?
|
Hemodynamics | 2 | 2019 | 4194 | 0.080 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1238 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3728 | 0.070 |
Why?
|
Safety | 1 | 2012 | 1159 | 0.070 |
Why?
|
DNA, Neoplasm | 1 | 2013 | 1744 | 0.070 |
Why?
|
Cocaine | 1 | 1992 | 947 | 0.070 |
Why?
|
Emergencies | 1 | 2014 | 1221 | 0.070 |
Why?
|
Incidental Findings | 1 | 2012 | 698 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2434 | 0.070 |
Why?
|
Neoplasm Metastasis | 1 | 2018 | 4912 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 840 | 0.070 |
Why?
|
Anesthesia | 1 | 2018 | 1596 | 0.070 |
Why?
|
Lymphoma | 1 | 2016 | 1898 | 0.070 |
Why?
|
Celiac Disease | 1 | 1994 | 820 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2014 | 1397 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12543 | 0.070 |
Why?
|
Observer Variation | 3 | 2021 | 2622 | 0.070 |
Why?
|
Perioperative Care | 1 | 2014 | 1043 | 0.060 |
Why?
|
Norepinephrine | 1 | 2008 | 898 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2257 | 0.060 |
Why?
|
Insurance, Health | 1 | 2018 | 2517 | 0.060 |
Why?
|
Intestinal Neoplasms | 1 | 2008 | 314 | 0.060 |
Why?
|
Equipment Safety | 1 | 2006 | 250 | 0.060 |
Why?
|
Geriatric Assessment | 1 | 2013 | 1422 | 0.060 |
Why?
|
Hypertrophy | 1 | 2007 | 562 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2007 | 5315 | 0.060 |
Why?
|
Lactulose | 2 | 1995 | 32 | 0.060 |
Why?
|
Health Care Costs | 1 | 2018 | 3239 | 0.060 |
Why?
|
Swine, Miniature | 1 | 2007 | 965 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2017 | 26379 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2840 | 0.060 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4120 | 0.060 |
Why?
|
Administration, Rectal | 1 | 2024 | 69 | 0.060 |
Why?
|
Heartburn | 1 | 2004 | 71 | 0.060 |
Why?
|
Anemia, Sickle Cell | 1 | 1992 | 1065 | 0.060 |
Why?
|
Mass Screening | 2 | 2021 | 5458 | 0.060 |
Why?
|
Mannitol | 2 | 1995 | 176 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1298 | 0.060 |
Why?
|
Paraneoplastic Cerebellar Degeneration | 1 | 2003 | 13 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2009 | 1443 | 0.050 |
Why?
|
Drug Resistance | 1 | 2009 | 1599 | 0.050 |
Why?
|
Metabolomics | 1 | 2013 | 1674 | 0.050 |
Why?
|
Role | 2 | 2014 | 176 | 0.050 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2009 | 617 | 0.050 |
Why?
|
Fluoroscopy | 1 | 2007 | 947 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2015 | 2442 | 0.050 |
Why?
|
Heart Atria | 1 | 2009 | 1361 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10399 | 0.050 |
Why?
|
Patient Selection | 1 | 2015 | 4260 | 0.050 |
Why?
|
Bacteria | 1 | 1994 | 2216 | 0.050 |
Why?
|
Abdominal Pain | 2 | 2006 | 1070 | 0.050 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3780 | 0.050 |
Why?
|
Duodenal Neoplasms | 1 | 2003 | 114 | 0.050 |
Why?
|
Palliative Care | 3 | 2010 | 3643 | 0.050 |
Why?
|
Injections | 1 | 2005 | 840 | 0.050 |
Why?
|
Thoracoscopy | 1 | 2003 | 186 | 0.050 |
Why?
|
Carcinoma in Situ | 2 | 2019 | 788 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2015 | 3620 | 0.050 |
Why?
|
Duodenal Obstruction | 1 | 2001 | 23 | 0.050 |
Why?
|
Postoperative Period | 1 | 2007 | 1826 | 0.050 |
Why?
|
Plasmapheresis | 2 | 2000 | 206 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4786 | 0.050 |
Why?
|
Peptide Fragments | 1 | 1994 | 5151 | 0.050 |
Why?
|
Ablation Techniques | 2 | 2016 | 255 | 0.050 |
Why?
|
Biopsy | 1 | 2013 | 6793 | 0.050 |
Why?
|
Urinalysis | 2 | 2014 | 370 | 0.050 |
Why?
|
Equipment Design | 2 | 2010 | 3522 | 0.050 |
Why?
|
Heparin | 1 | 2008 | 1636 | 0.050 |
Why?
|
Gastric Outlet Obstruction | 1 | 2001 | 55 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2014 | 3929 | 0.040 |
Why?
|
Medicare | 1 | 2019 | 6809 | 0.040 |
Why?
|
Pancreatic Ducts | 1 | 2002 | 330 | 0.040 |
Why?
|
Color | 1 | 2021 | 296 | 0.040 |
Why?
|
Tomography, Emission-Computed | 1 | 2003 | 1126 | 0.040 |
Why?
|
Ethanol | 2 | 2016 | 1331 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2014 | 4055 | 0.040 |
Why?
|
Feces | 2 | 1999 | 1511 | 0.040 |
Why?
|
Porphyria, Hepatoerythropoietic | 1 | 1999 | 8 | 0.040 |
Why?
|
Blood Group Incompatibility | 1 | 2000 | 134 | 0.040 |
Why?
|
Digestive System Surgical Procedures | 1 | 2005 | 583 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18349 | 0.040 |
Why?
|
Sex Factors | 2 | 2019 | 10632 | 0.040 |
Why?
|
Lactose | 1 | 1999 | 95 | 0.040 |
Why?
|
Pepsinogens | 2 | 1996 | 7 | 0.040 |
Why?
|
Colitis, Ulcerative | 1 | 2011 | 1926 | 0.040 |
Why?
|
Asymptomatic Diseases | 2 | 2012 | 590 | 0.040 |
Why?
|
Metals | 2 | 2010 | 713 | 0.040 |
Why?
|
Primary Health Care | 1 | 2015 | 4746 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2004 | 1791 | 0.040 |
Why?
|
Hydrogen | 1 | 1999 | 171 | 0.040 |
Why?
|
Crohn Disease | 1 | 2011 | 2295 | 0.040 |
Why?
|
Forecasting | 1 | 2007 | 2945 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14783 | 0.040 |
Why?
|
Mycophenolic Acid | 1 | 2000 | 348 | 0.040 |
Why?
|
Survival Rate | 2 | 2006 | 12840 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2019 | 1474 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2024 | 2271 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3533 | 0.040 |
Why?
|
Breath Tests | 1 | 1999 | 300 | 0.040 |
Why?
|
Liver Transplantation | 2 | 2000 | 2401 | 0.040 |
Why?
|
Learning Curve | 1 | 2019 | 232 | 0.040 |
Why?
|
Intestinal Obstruction | 1 | 2001 | 433 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2012 | 4058 | 0.030 |
Why?
|
Heme | 1 | 1999 | 316 | 0.030 |
Why?
|
Gastric Mucosa | 3 | 2013 | 602 | 0.030 |
Why?
|
Esophageal Perforation | 2 | 2013 | 65 | 0.030 |
Why?
|
Microsporida | 1 | 1996 | 6 | 0.030 |
Why?
|
Parenteral Nutrition, Total | 1 | 1997 | 304 | 0.030 |
Why?
|
Skinfold Thickness | 1 | 1996 | 164 | 0.030 |
Why?
|
Albumins | 1 | 1999 | 577 | 0.030 |
Why?
|
Hemochromatosis | 1 | 1997 | 175 | 0.030 |
Why?
|
Erythrocyte Transfusion | 1 | 2021 | 575 | 0.030 |
Why?
|
Microsporidiosis | 1 | 1996 | 23 | 0.030 |
Why?
|
Double-Balloon Enteroscopy | 1 | 2015 | 7 | 0.030 |
Why?
|
Substance-Related Disorders | 1 | 1992 | 4423 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7477 | 0.030 |
Why?
|
Computer-Assisted Instruction | 1 | 2019 | 366 | 0.030 |
Why?
|
Animals | 5 | 2010 | 169246 | 0.030 |
Why?
|
Prevalence | 3 | 2019 | 15869 | 0.030 |
Why?
|
Nutrition Disorders | 1 | 1996 | 204 | 0.030 |
Why?
|
Sphincter of Oddi Dysfunction | 1 | 2015 | 5 | 0.030 |
Why?
|
Injections, Intralesional | 1 | 2016 | 280 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2004 | 3556 | 0.030 |
Why?
|
Esophageal Stenosis | 2 | 1995 | 196 | 0.030 |
Why?
|
Gastric Acidity Determination | 1 | 1994 | 56 | 0.030 |
Why?
|
Micronutrients | 1 | 1998 | 390 | 0.030 |
Why?
|
Light | 1 | 2021 | 1355 | 0.030 |
Why?
|
Solvents | 1 | 2016 | 298 | 0.030 |
Why?
|
Cholecystitis | 1 | 1996 | 181 | 0.030 |
Why?
|
Hydrochloric Acid | 1 | 1994 | 76 | 0.030 |
Why?
|
Absorption | 1 | 1994 | 244 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 2004 | 1183 | 0.030 |
Why?
|
Carcinoembryonic Antigen | 1 | 2016 | 338 | 0.030 |
Why?
|
Pyloric Antrum | 1 | 1995 | 66 | 0.030 |
Why?
|
Angiodysplasia | 1 | 1995 | 22 | 0.030 |
Why?
|
Anesthetics, Intravenous | 1 | 2018 | 397 | 0.030 |
Why?
|
Autoantibodies | 1 | 2003 | 2121 | 0.030 |
Why?
|
Choledocholithiasis | 1 | 2015 | 50 | 0.030 |
Why?
|
Flavoring Agents | 1 | 2015 | 53 | 0.030 |
Why?
|
Xylose | 1 | 1994 | 28 | 0.030 |
Why?
|
Child | 3 | 2018 | 80917 | 0.030 |
Why?
|
Pregnancy Tests | 1 | 2014 | 33 | 0.030 |
Why?
|
Radioimmunoassay | 1 | 1994 | 863 | 0.030 |
Why?
|
Phosphorus | 1 | 1995 | 336 | 0.030 |
Why?
|
Gastric Emptying | 1 | 1996 | 247 | 0.030 |
Why?
|
Delphi Technique | 1 | 2018 | 891 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 1994 | 351 | 0.030 |
Why?
|
Fats | 1 | 1994 | 99 | 0.030 |
Why?
|
Massachusetts | 1 | 2006 | 8890 | 0.030 |
Why?
|
Consensus | 2 | 2018 | 3212 | 0.030 |
Why?
|
Survival Analysis | 3 | 2019 | 10101 | 0.030 |
Why?
|
Colectomy | 1 | 2018 | 696 | 0.030 |
Why?
|
Proctoscopy | 1 | 2013 | 40 | 0.030 |
Why?
|
Keratoderma, Palmoplantar, Diffuse | 1 | 2012 | 3 | 0.030 |
Why?
|
Raynaud Disease | 1 | 1994 | 81 | 0.030 |
Why?
|
Hematemesis | 1 | 2013 | 22 | 0.030 |
Why?
|
Sclerotherapy | 1 | 2014 | 183 | 0.030 |
Why?
|
Blood Coagulation Tests | 1 | 2014 | 270 | 0.030 |
Why?
|
Ultrasonography | 2 | 2004 | 6004 | 0.030 |
Why?
|
Chlorides | 1 | 1996 | 666 | 0.030 |
Why?
|
Permeability | 1 | 1995 | 725 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2013 | 162 | 0.030 |
Why?
|
Hematocrit | 1 | 2014 | 623 | 0.030 |
Why?
|
Colitis, Microscopic | 1 | 2013 | 71 | 0.030 |
Why?
|
Bicycling | 1 | 1994 | 177 | 0.030 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1996 | 664 | 0.020 |
Why?
|
Esophagitis | 1 | 2013 | 164 | 0.020 |
Why?
|
Duodenum | 1 | 1995 | 495 | 0.020 |
Why?
|
Gastritis | 1 | 1994 | 199 | 0.020 |
Why?
|
Hypertension, Portal | 1 | 2014 | 230 | 0.020 |
Why?
|
Tumor Burden | 1 | 2018 | 1906 | 0.020 |
Why?
|
Carbohydrates | 1 | 1994 | 389 | 0.020 |
Why?
|
Total Quality Management | 1 | 2013 | 265 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 2013 | 297 | 0.020 |
Why?
|
Propofol | 1 | 2018 | 608 | 0.020 |
Why?
|
Burns, Chemical | 1 | 2012 | 123 | 0.020 |
Why?
|
Fluid Therapy | 1 | 1996 | 587 | 0.020 |
Why?
|
Esophageal Achalasia | 1 | 2012 | 98 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2018 | 1138 | 0.020 |
Why?
|
Polyps | 1 | 2013 | 200 | 0.020 |
Why?
|
Quality Control | 1 | 2014 | 836 | 0.020 |
Why?
|
Anthropometry | 1 | 1996 | 1346 | 0.020 |
Why?
|
Heredity | 1 | 2012 | 149 | 0.020 |
Why?
|
Pilot Projects | 1 | 2005 | 8741 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 2021 | 1402 | 0.020 |
Why?
|
Laparoscopy | 1 | 2003 | 2041 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3603 | 0.020 |
Why?
|
Cardiovascular Diseases | 3 | 2019 | 15662 | 0.020 |
Why?
|
Peritonitis | 1 | 2013 | 368 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2003 | 4413 | 0.020 |
Why?
|
Sarcoma | 1 | 2001 | 1806 | 0.020 |
Why?
|
Genes, ras | 1 | 2013 | 663 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1999 | 6229 | 0.020 |
Why?
|
Eosinophilic Esophagitis | 1 | 2013 | 205 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2013 | 627 | 0.020 |
Why?
|
Health | 1 | 2013 | 398 | 0.020 |
Why?
|
Cysts | 1 | 1995 | 685 | 0.020 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1191 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2013 | 541 | 0.020 |
Why?
|
Graft Survival | 1 | 2000 | 3887 | 0.020 |
Why?
|
Creatinine | 1 | 1995 | 1918 | 0.020 |
Why?
|
Cytodiagnosis | 1 | 2013 | 452 | 0.020 |
Why?
|
Diarrhea | 1 | 1996 | 1320 | 0.020 |
Why?
|
Iron | 1 | 1997 | 1813 | 0.020 |
Why?
|
Antigens | 1 | 1994 | 1442 | 0.020 |
Why?
|
Esophagectomy | 1 | 2012 | 481 | 0.020 |
Why?
|
Preoperative Care | 1 | 2018 | 2258 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 2013 | 2000 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1733 | 0.020 |
Why?
|
Analgesia | 1 | 2013 | 460 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1243 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2000 | 4568 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2013 | 1836 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 2013 | 956 | 0.020 |
Why?
|
Algorithms | 4 | 2015 | 14164 | 0.020 |
Why?
|
Protons | 1 | 2013 | 1113 | 0.020 |
Why?
|
Anesthesiology | 1 | 2018 | 1137 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2000 | 4206 | 0.020 |
Why?
|
Analgesics | 1 | 2014 | 1071 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1832 | 0.020 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2007 | 61 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 89169 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2420 | 0.020 |
Why?
|
Administration, Oral | 1 | 1994 | 4030 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36743 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2015 | 2191 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10760 | 0.020 |
Why?
|
Epithelium | 1 | 2011 | 1607 | 0.020 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2008 | 361 | 0.020 |
Why?
|
Bacteremia | 1 | 2013 | 986 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3671 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 9615 | 0.020 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2005 | 13 | 0.020 |
Why?
|
Metabolome | 1 | 2013 | 1009 | 0.020 |
Why?
|
Peristalsis | 1 | 2005 | 60 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2862 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2013 | 3620 | 0.010 |
Why?
|
Chronic Disease | 2 | 2014 | 9384 | 0.010 |
Why?
|
Monitoring, Ambulatory | 1 | 2007 | 358 | 0.010 |
Why?
|
Pedigree | 1 | 2012 | 4539 | 0.010 |
Why?
|
Life Tables | 1 | 2004 | 367 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1667 | 0.010 |
Why?
|
Colostomy | 1 | 2004 | 106 | 0.010 |
Why?
|
Brunner Glands | 1 | 2003 | 11 | 0.010 |
Why?
|
Burns | 1 | 1995 | 1899 | 0.010 |
Why?
|
Weight Loss | 1 | 2015 | 2721 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2000 | 9263 | 0.010 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 13676 | 0.010 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2013 | 1250 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13421 | 0.010 |
Why?
|
Manometry | 1 | 2005 | 459 | 0.010 |
Why?
|
Protein Binding | 1 | 1994 | 9343 | 0.010 |
Why?
|
Infant | 2 | 2015 | 36535 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1995 | 2517 | 0.010 |
Why?
|
Mutation | 2 | 2019 | 30238 | 0.010 |
Why?
|
Liver | 1 | 1997 | 7577 | 0.010 |
Why?
|
Pressure | 1 | 2005 | 1172 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 17622 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3837 | 0.010 |
Why?
|
Disease Progression | 1 | 2018 | 13671 | 0.010 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2003 | 219 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2784 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4978 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3706 | 0.010 |
Why?
|
Electrocardiography | 1 | 2014 | 6412 | 0.010 |
Why?
|
Stomach | 2 | 1995 | 701 | 0.010 |
Why?
|
Markov Chains | 1 | 2004 | 979 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6847 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11095 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 60066 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6669 | 0.010 |
Why?
|
Autoantigens | 1 | 2003 | 890 | 0.010 |
Why?
|
SEER Program | 1 | 2004 | 1444 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2009 | 9419 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2015 | 5520 | 0.010 |
Why?
|
Quality-Adjusted Life Years | 1 | 2004 | 1741 | 0.010 |
Why?
|
Life Expectancy | 1 | 2004 | 1248 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1999 | 1377 | 0.010 |
Why?
|
Gastric Juice | 1 | 1996 | 59 | 0.010 |
Why?
|
Transferrin | 1 | 1997 | 283 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2006 | 6316 | 0.010 |
Why?
|
Alcohol Dehydrogenase | 1 | 1996 | 113 | 0.010 |
Why?
|
Tetracycline | 1 | 1996 | 216 | 0.010 |
Why?
|
Probability | 1 | 2001 | 2479 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2006 | 2100 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22291 | 0.010 |
Why?
|
Food Analysis | 1 | 1995 | 103 | 0.010 |
Why?
|
Aspirin | 1 | 2006 | 3135 | 0.010 |
Why?
|
Ferritins | 1 | 1997 | 601 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1996 | 1627 | 0.010 |
Why?
|
Dilatation | 1 | 1995 | 311 | 0.010 |
Why?
|
Postoperative Care | 1 | 2000 | 1480 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2014 | 26422 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2005 | 2593 | 0.010 |
Why?
|
Homozygote | 1 | 1997 | 1779 | 0.010 |
Why?
|
Ibuprofen | 1 | 1994 | 229 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2005 | 5536 | 0.010 |
Why?
|
Magnesium | 1 | 1995 | 815 | 0.010 |
Why?
|
Zinc | 1 | 1995 | 677 | 0.010 |
Why?
|
Equipment Failure | 1 | 1993 | 585 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 42669 | 0.010 |
Why?
|
Heterozygote | 1 | 1997 | 2798 | 0.010 |
Why?
|
Catheterization | 1 | 1995 | 1430 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 18065 | 0.010 |
Why?
|
Liver Diseases | 1 | 1997 | 1305 | 0.000 |
Why?
|
Breast Neoplasms | 1 | 1995 | 21206 | 0.000 |
Why?
|
Regression Analysis | 1 | 1997 | 6340 | 0.000 |
Why?
|
Data Collection | 1 | 1996 | 3327 | 0.000 |
Why?
|
Calcium | 1 | 1995 | 5792 | 0.000 |
Why?
|